• Scheme Booklet registered with ASIC
• Independent Expert concludes Scheme is fair and reasonable
• Cannatrek Board unanimously recommends Scheme, subject to no Superior Proposal

Little Green Pharma Ltd (ASX: LGP) has registered the Scheme Booklet with ASIC for the proposed acquisition of 100% of the issued capital of Cannatrek Ltd (Cannatrek) by way of scheme of arrangement. The Scheme Booklet includes important information including the reasons why Cannatrek Shareholders may wish to vote in favour of or against the Scheme Resolution, and details regarding LGP's intentions in respect of Cannatrek from implementation of the Scheme (including key risks). The Independent Expert has concluded that the Scheme is fair and reasonable and that the Scheme is in the best interests of Cannatrek Shareholders, in the absence of a Superior Proposal. The Cannatrek Board has unanimously recommended that Cannatrek Shareholders vote in favour of the Scheme, in the absence of a Superior Proposal and subject to the Independent Expert concluding (and continuing to conclude) that the Scheme is in the best interests of Cannatrek shareholders. Subject to those same qualifications, each Cannatrek Director intends to vote (or procure the voting of) all Cannatrek Shares held or controlled by them at the time of the Scheme Meeting in favour of the Scheme. The LGP Board unanimously recommends that LGP Shareholders vote in favour of the LGP Resolutions that are required to be approved by LGP Shareholders as a condition of the Scheme.